INSTRUCTIONS FOR AUTHORS
1. SUMMARY OF SUBMISSION
Thank you for your interest in Cumhuriyet Medical Journal. Please read the complete Author Guidelines carefully prior to submission, including the section on copyright.
Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://dergipark.org.tr/cmj. For help with submissions, please contact email@example.com forward to your submission.
2. EDITORIAL CONSIDERATIONS
Aims and Scope
Cumhuriyet Medical Journal is the official peer-reviewed publication of Cumhuriyet University School of Medicine, in Turkey. The journal aims to provide a forum for the exchange of information about new and significant research in medical sciences. Research articles, reviews, case reports and letters to the editor are published. Papers in all medical fields will be considered.
Editorial Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer-reviewed by two reviewers and the Editors. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
Instructions: only relevant if
your Journal publishes human studies
For manuscripts reporting medical studies involving human participants, we require a statement identifying the ethics committee that approved the study, and that the study conforms to recognized standards, for example:
Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Patient anonymity should be preserved. Non-essential identifying details should be omitted.
Editors may request that reviewers comment on the standard of experimental reporting, experimental design, or any other aspects of the study reported that may cause concern. If concerns are raised or clarifications are needed, we may need to request evidence of ethical research approval.
Conflict of Interest
We require that all authors disclose any potential sources of conflict of interest. The existence of a conflict of interest does not preclude publication. A conflict of interest statement must be included within the manuscript (see section ‘Parts of the Manuscript’), and authors must also complete a Conflict of Interest form. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company.
Completion of the form is mandatory for all article categories. If the form is not included or complete, the manuscript will not be considered for peer review.
The authors should list all funding sources in the Acknowledgments section.
The journal adheres to the . The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and iv) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.
3. MANUSCRIPT CATEGORIES AND
Word limit: 6,500 words including abstract.
Figures/Tables: No limit
References: No limit.
Description: Arrange text as follows: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) conflict of interest, (vi) references, (vii) supporting information, (viii) figure legends, (ix) tables (each table complete with title and footnotes) and (x) figures. Footnotes to the text is not allowed and any such material should be incorporated into the text as parenthetical matter.
Word limit: 5,000 words.
References: No limit.
Figures/tables: No limit. (Minimum 1 image or figure)
Description: Reviews are comprehensive analyses of specific topics. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.
Word limit: 2500 words
Authors: Maximum ten authors.
Abstract: No structured.
References: Up to 10.
Figures/ tables: No limit (Multi-panel figures allowed).
Description: Concise descriptions detailing one or two patients, early reports of therapeutic trials in one or several patients, and early reports of new drug reactions. Arrange text as follows: (i) title page, (ii) abstract and keywords, (iii) text, (iv) acknowledgments, (v) conflict of interest, (vi) references, (vii) supporting information, (viii) figure legends, (ix) tables (each table complete with title and footnotes) and (x) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Letters to the Editor
Word limit: 500 words
Authors: Maximum ten authors.
Abstract: No abstract.
References: Up to 5.
Figures/ tables: Up to 1 (Multi-panel figures allowed).
Description: The journal publishes two types of Letters to the Editor, listed below. Letters to the Editor of one printed pages or less will be published as soon as possible.
(i) Notes & Comments: Letters may be submitted to the Editor on any topic of discussion; clinical observations as well as letters commenting on papers published in recent issues.
(ii) Case Letters: Conclusions based on uncontrolled trials and/or limited experience should be stated inappropriately tentative terms. Concise descriptions detailing one or two patients, early reports of therapeutic trials in one or several patients, and early reports of new drug reactions.
4. PREPARING THE MANUSCRIPT
Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at Units: All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at for more information about SI units.
Abbreviations: Abbreviations should be used sparingly -only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Trade names: Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
Parts of the Manuscript
The length of manuscripts must adhere to the specifications under the section Manuscript Categories.
Manuscripts should be presented in the following order: (i) title page, (ii) abstract and keywords, (iii) text, (iv) acknowledgments, (v) conflict of interest statement, (vi) references, (viii) figure legends, and (ix) tables (each table complete with title and footnotes). Figures and supporting information should be supplied in separate files.
The title page should contain:
(i) a short informative title that contains the major keywords. The title should not contain abbreviations
(ii) the names and institutional affiliations of all authors;
(iii) a short running title (no more than 40 characters, abbreviations are permitted)
The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
Abstract and keywords
All articles must have a brief abstract that states in 300 words the purpose, basic procedures, main findings and principal conclusions of the study. The abstract should not contain abbreviations or references. The abstract must be structured as Introduction, aim, materials and methods, results and conclusion.
Five keywords, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list at .
For research articles: Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Materials, and Methods, Results, Discussion, and Conclusion
For case reports: Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Case (If there are more than In one case, the cases should be numbered. İ.e., Case 1, Case 2…), Discussion and Conclusion
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement
(applies to all article types)
In this section, authors must describe any interest or relationship, financial or otherwise, that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The absence of any interest to disclose must also be stated.
References follow the Vancouver style, i.e. numbered sequentially as they occur in the text and ordered numerically in the reference list.
• All citations mentioned in the text, tables or figures must be listed in the reference list.
• If cited in tables or figure legends, number according to the first identification of the table or figure in the text.
• Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Golden R, 2000, unpublished data).
• The authors are responsible for the accuracy of the references.
• Cite the names of all authors when there are five or fewer; when six or more, list the first three followed by et al.
Smith S, Gunsel T, Tufan S, Stronfamily A, Whiteway M. Example of reference title. J CM 2017; 32: 12-7.
<Cite article has more than six authors, list the first three followed by et al.>
Strongfamily A, Whiteway M, Smith S et al. Another example of reference title. J CM 2017; 126: 303-11.
Online Article Not Yet Published in an Issue
An online article that has not yet been published in an issue (therefore has no volume, issue or page numbers) can be cited by its Digital Object Identifier (DOI). The DOI will remain valid and allow an article to be tracked even after its allocation to an issue.
Strongfamily A, Whiteway M. Third example of reference title. J CM 2017. DOI: 21.4002/iag.91.
Strongfamily A, Whiteway M (eds). Hyperpigmentations, 4th edn. Sivas: Cumhuriyet University Press, 2017.
Chapter in a Book
Strongfamily A, Whiteway M. Hypopigmentations. In: Coresteel S (ed). The Color, Vol 2, first edn. Sivas: Cumhuriyet University Press, 2017; 58-85.
Zosters.org [homepage on the Internet]. Sivas: Association of varicella Online Resources, Inc.; c2000–01 [Cited 2017 April 4]. Available from: .
Tables should be self-contained and complement, but not duplicate, the information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. Figure legends should be included in the main text document.
Although we encourage authors to send us the highest-quality figures possible, for peer-review purposes, we are happy to accept a wide variety of formats, sizes, and resolutions.
Color figures: Figures submitted in color may be reproduced in color online and in print free of charge if they are of sufficient quality (300 dpi). Please note, however, that it is preferable that line figures (eg graphs and charts) and supplied in black and white so that they are legible if printed by a reader in black and white.
5. SUBMISSION OF MANUSCRIPTS
Manuscripts should be submitted online at the home page (https://dergipark.org.tr/cmj)
• A cover letter and a conflict of interest form should be uploaded.
• Each figure should be supplied as a separate file, with the figure
number incorporated in the file name. Multi-panel figures (figures with parts
a, b, c, d, etc.) should be submitted as a single file that contains all parts
of the figure. For submission, high-resolution figures (300 dpi) saved as .jpg
or .bmp files should be uploaded.
• Author material archive policy, authors who require the return of any submitted material that is accepted for publication should inform the Editorial Office after acceptance. If no indication is given that author material should be returned, CMJ will dispose of all hardcopy and electronic material two months after publication.
There is no publication charge.
Cumhuriyet Medical Journal
Assoc. Prof. Dr. Ahmet ALTUN
Cumhuriyet University School of Medicine
Department of Pharmacology